The National Disease Research Interchange - NDRI

Home
United States
Philadelphia, PA
The National Disease Research Interchange - NDRI

The National Disease Research Interchange (NDRI) is a Philadelphia based 501 (c) (3) non-profit, NIH-
(1)

12/23/2025

Wishing everyone a joyful holiday season. We’re grateful for your continued collaboration in advancing biomedical research!

12/10/2025

The shape, texture, and surface patterns of the tongue (including grooves and bumps) are unique to each individual and can be used for biometric identification in research.

12/04/2025

HIV research depends on human tissue to answer questions that no other model can. Through our HIV Donor Program, HIV-positive donors help scientists better understand how the virus persists and how future treatments can improve. If you or someone you love is thinking about donation, NDRI’s Private HIV Donor Program is here to support you and help your gift reach researchers who need it. 📞 (800) 222 NDRI (6374), Option 5

11/27/2025

We’re grateful for the generosity that makes biomedical research possible. To the donors and families who give the gift of hope, to our clinical partners and organ procurement organizations who help make each donation possible, to the researchers striving every day to discover new cures, and to everyone across the NDRI community who believes in the power of science. You have our heartfelt thanks. Wishing you a warm and restful Thanksgiving.

11/26/2025

Our partners at have released their 2025 Impact Update. It highlights incredible accomplishments made possible through generous donor support. As Brandon Jutra, PhD, of Northwestern University’s Feinberg School of Medicine, shares: “Bay Area Lyme Foundation has been instrumental in supporting bold, discovery-driven research that challenges long-held assumptions about Lyme disease biology. Their commitment to scientific innovation allows us to pursue ideas that can fundamentally change how we understand, diagnose, and ultimately treat this complex, multifactorial infection.” Read the report: https://hubs.la/Q03VV6dy0

11/25/2025

Diabetic retinal disease (DRD) is a major cause of vision loss worldwide, and current treatments often address only the later stages of the condition. New research, published in , supported by NDRI-sourced and generously donated human tissue, identifies a potential treatment that may help preserve vision in individuals with diabetic retinal disease.

11/19/2025

Researchers are developing a gene therapy that helps prevent heart failure by restoring calcium balance inside its cells. Using generously donated human heart tissue, sourced by NDRI, a Phase 1study has confirmed the safety and feasibility of the treatment, bringing us closer to new treatments for heart failure.

11/06/2025

Humans have a vestigial third eyelid called the plica semilunaris, a small, half-moon fold of tissue in the inner corner of the eye. It’s a remnant of a full, functioning nictitating membrane found in many other animals, which helps protect and clean the eye. Cool, right? 👁️

10/30/2025

Today we honor Daniel Nathans, the pioneering microbiologist who helped launch modern biotechnology. In 1978, Nathans shared the Nobel Prize in Physiology or Medicine for discovering restriction enzymes, the molecular “scissors” that cut DNA at precise sites and enabled restriction mapping. His work laid the foundation for genetic engineering, recombinant DNA technology, genome sequencing, and many tools used in biomedical research today.

10/17/2025

Continuing on our October Breast Cancer Awareness series, this week we're shining a light on male breast cancer. Everyone has breast tissue, which means men can get breast cancer too. While it's rare, accounting for approximately 1% of all U.S. breast cancer diagnoses, men often face a higher mortality rate largely because of later detection. Early awareness saves lives.

10/02/2025

For people living with HIV, today’s medicines are remarkably effective. Antiretroviral therapy (ART) can reduce the amount of virus in the blood to undetectable levels, restoring immune health and preventing transmission. But ART is not a cure, and when treatment stops the virus returns quickly. A new study, using NDRI-sourced tissue donations, helps explain why. Read story: https://hubs.la/Q03L_Hsb0

Address

Three Parkway, 1601 Cherry Street, Suite 1700
Philadelphia, PA
19103

Telephone

+12155577361

Website

http://www.ndriresource.org/

Alerts

Be the first to know and let us send you an email when The National Disease Research Interchange - NDRI posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Philadelphia?

NDRI’s History

Founded in 1980 by Lee Ducat, the National Disease Research Interchange (NDRI) is a 501(c)(3) not-for-profit organization that provides human biospecimens to scientists in academic, corporate and independent research organizations throughout the world. We serve as a Human Tissue and Organ for Research Resource (HTORR). The National Institutes of Health (NIH) has supported our work for more than 30 consecutive years. Our unparalleled tissue recovery network includes some 130 partners comprised of organ procurement organizations, eye banks, tissue banks and hospitals, and our biorepository facility is accredited by the College of American Pathologists (CAP). Utilizing the expertise of NDRI staff and that of our recovery partners, we provide anatomical structures, organs, and tissues with annotated data to support research across the full spectrum of disease and disability.